Acton, MA, United States of America

Brian Dean Phenix



 

Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Brian Dean Phenix: Innovator in Pharmaceutical Compositions

Introduction

Brian Dean Phenix is a notable inventor based in Acton, MA (US), recognized for his contributions to the field of pharmaceutical compositions. He holds a total of three patents, focusing on innovative treatments for cystic fibrosis and related diseases. His work has significantly impacted the development of therapeutic agents aimed at enhancing patient outcomes.

Latest Patents

Among his latest patents, Brian has developed compositions that comprise a plurality of therapeutic agents. These agents work synergistically, enhancing the properties of one another. Specifically, his inventions include cystic fibrosis transmembrane conductance regulators (CFTR), such as CFTR correctors or potentiators, which are crucial for treating CFTR-mediated diseases like cystic fibrosis. The patents also disclose methods and kits for utilizing these compositions effectively.

Career Highlights

Brian Dean Phenix is currently associated with Vertex Pharmaceuticals, Inc., a leading company in the biotechnology sector. His role at Vertex has allowed him to collaborate with other experts in the field, further advancing the research and development of innovative treatments.

Collaborations

Throughout his career, Brian has worked alongside notable colleagues, including Laurent Jean-Claude Bagnol and Geoffrey Glen Brodeur. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects.

Conclusion

Brian Dean Phenix exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborative efforts continue to pave the way for advancements in the treatment of cystic fibrosis and related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…